ESOP/ISOP reimbursement is not capital or contingent expense: ITAT Mumbai deletes disallowance u/s 37

Procter & Gamble Hygiene & Health Care Ltd Vs Assessment Unit (ITAT Mumbai)

ESOP reimbursement not capital or contingent: ITAT Mumbai deletes disallowance u/s 37

ITAT Mumbai allowed the appeal of Procter & Gamble Hygiene & Health Care Ltd., deleting a disallowance of ₹11.17 crore u/s 37(1) related to employee benefit expenses incurred for ESOP & ISOP schemes offered by its US-based holding company.

The parent company (Procter & Gamble Co., USA) offered ESOP (Employee Stock Option Plan): Stock-based incentives based on vesting

Please become a Premium member. If you are already a Premium member, login here to access the full content.